Institute of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Department of Nephrology, RuiJin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin Er Road, Shanghai, 200025, China.
Clin Exp Nephrol. 2019 Jul;23(7):871-879. doi: 10.1007/s10157-019-01705-w. Epub 2019 Feb 8.
Epidemiological studies suggest that higher serum uric acid (SUA) level is significantly associated with kidney disease development. However, it remains debatable whether higher SUA is independently associated with new-onset kidney disease and rapid eGFR decline in individuals with estimated glomerular filtration rate (eGFR) ≥ 60 mL/min/1.73 m and negative proteinuria.
This was a large, single-center, retrospective 6-year cohort study at People's Hospital of Tonglu County, Zhejiang, from 2001 to 2006. We enrolled 10,677 participants (19-92 years) with eGFR ≥ 60 mL/min/1.73 m and without dipstick proteinuria at baseline. The association between SUA change and the occurrence of renal outcomes and annual eGFR decline were evaluated using Cox models with adjustment for confounders.
Higher quartiles (2.51%) of SUA levels were associated with greater prevalence of kidney disease compared with quartile 1 (0.52%), 2 (1.13%) and 3 (1.76%), respectively. In addition, greater baseline SUA levels [OR (95% CI) 3.29(1.68-6.45), p < 0.001] and increased SUA [1.36(1.23-1.50), p < 0.001] were all associated with greater odds of renal disease progression when comparing the 4th quartile of annual eGFR decline rate with the 1st quartile. In addition, both of higher baseline SUA levels and increased SUA change were the risk factors of rapid annual eGFR decline along with male gender, lower albumin, hematocrit and creatinine levels, higher hemoglobin levels and hyperlipidemia after multivariable adjustments when compared with each quartile group.
Increasing SUA were independent risk factor for the prevalent of kidney disease and rapid eGFR decline and reduced SUA over time could abate kidney disease development in a Chinese community.
流行病学研究表明,血清尿酸(SUA)水平升高与肾脏疾病的发生发展显著相关。然而,对于估算肾小球滤过率(eGFR)≥60mL/min/1.73m 且无蛋白尿的个体中,SUA 水平升高是否与新发生的肾脏疾病和 eGFR 快速下降独立相关,仍存在争议。
这是一项来自 2001 年至 2006 年期间浙江省桐庐县人民医院的大型、单中心、回顾性 6 年队列研究。我们纳入了 10677 名基线时 eGFR≥60mL/min/1.73m 且无尿蛋白试纸检测蛋白尿的患者。使用 Cox 模型评估 SUA 变化与肾脏结局和 eGFR 年下降率的发生之间的关系,并进行了混杂因素调整。
与 quartile 1(0.52%)、quartile 2(1.13%)和 quartile 3(1.76%)相比,更高 quartile(2.51%)的 SUA 水平与更高的肾脏疾病患病率相关。此外,基线时较高的 SUA 水平[比值比(95%可信区间)3.29(1.68-6.45),p<0.001]和 SUA 升高[1.36(1.23-1.50),p<0.001]均与 4 组 eGFR 年下降率与 1 组相比,肾脏疾病进展的可能性更大相关。此外,与每个 quartile 组相比,基线时较高的 SUA 水平和 SUA 变化增加都是男性、白蛋白、血细胞比容和肌酐水平较低、血红蛋白水平较高和高血脂的快速 eGFR 下降的危险因素。
SUA 的升高是肾脏疾病和 eGFR 快速下降的独立危险因素,随着时间的推移,SUA 的降低可以减缓中国人群肾脏疾病的进展。